跳至主要内容
临床试验/ACTRN12619000170123
ACTRN12619000170123已完成未知

Evaluation of the lipid-lowering effects of the BruMeChol™ dietary supplement in subjects with mild hypercholesterolemia

IRCCS INRCA0 个研究点目标入组 125 人开始时间: 2019年2月5日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • blood total cholesterol levels between 200 and 250 mg/dL
  • - no history of clinically relevant cardiovascular events
  • - signed informed consent form

排除标准

  • - current therapy with statins or food supplements with lipid-reducing effect
  • - total cholesterol > 250 or < 200 mg/dl;
  • - therapy with anticoagulants;
  • - hypothyroidism, orhyperthyroidism
  • - insulin-dependent diabetes or diabetes associated with macrovascular complications)
  • - intestinal malabsorption;
  • - acute illnesses
  • - neoplastic disease or < 1-year life expectancy;
  • - statin non-related liver disease
  • - severe chronic renal failure
  • - allergy/intolerance to one or more components of dietary supplement or placebo
  • - participation in another clinical trial of intervention in the previous three months.
  • - presence of cognitive disorders and other impediments that do not guarantee the correct adherence to the study treatments;
  • - current or presumed pregnancy and pregnancy planning;
  • - incapacity, impossibility or unavailability to sign the written consent.

研究者

发起方
IRCCS INRCA

相似试验